Symbol="COCP"
AssetType="Common Stock"
Name="Cocrystal Pharma Inc"
Description="Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington."
CIK="1412486"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="19805 N. CREEK PARKWAY, BOTHELL, WA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="29504000"
EBITDA="-18855000"
PERatio="None"
PEGRatio="0"
BookValue="4.257"
DividendPerShare="0"
DividendYield="0"
EPS="-4.78"
RevenuePerShareTTM="0.006"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.21"
ReturnOnEquityTTM="-0.736"
RevenueTTM="510000"
GrossProfitTTM="-8794000"
DilutedEPSTTM="-4.78"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.269"
AnalystTargetPrice="9.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="92.45"
PriceToBookRatio="0.453"
EVToRevenue="17.89"
EVToEBITDA="0.577"
Beta="1.208"
num_52WeekHigh="6.24"
num_52WeekLow="1.74"
num_50DayMovingAverage="2.553"
num_200DayMovingAverage="2.421"
SharesOutstanding="10173800"
DividendDate="2018-01-24"
ExDividendDate="None"
symbol="COCP"
open="2.80"
high="3.07"
low="2.80"
price="3.01"
volume="39165.00"
latest_trading_day="2023-08-14"
previous_close="2.89"
change="0.12"
change_percent="4.1522%"
aroon_positive_momentum_days="51"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="56018"
Change_recent_avg="0.02"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="0.72"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="171"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0005.jpeg"
image_negative_thumbnail_id_2="509"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_neutral_thumbnail_id_1="533"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0066.jpeg"
image_neutral_thumbnail_id_2="583"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_positive_thumbnail_id_1="671"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0037.jpeg"
image_positive_thumbnail_id_2="610"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0098.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1171"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0005.jpeg"
